Prevalence and biopsychosocial indicators of fatigue in cancer patients
Elisabeth L. Zeilinger,Irina Zrnic‐Novakovic,Claudia Oppenauer,Matthäus Fellinger,Matthias Knefel,Matthias Unseld,Theresa Wagner,Simone Lubowitzki,Rupert Bartsch,Sabine Zöchbauer‐Müller,Markus Raderer,Philipp B. Staber,Peter Valent,Alexander Gaiger
DOI: https://doi.org/10.1002/cam4.7293
IF: 4.711
2024-06-01
Cancer Medicine
Abstract:Introduction Symptoms of cancer‐related fatigue (CRF) can have a significant impact on patients' quality of life and treatment adherence. We aimed to investigate the relationship between CRF and multiple psychosocial and somatic indicators within a large mixed cancer sample. Methods In this cross‐sectional study, N = 1787 outpatients with cancer were assessed for CRF, pain, anxiety, and depression using validated screening instruments. We further obtained clinical parameters (Hb, CRP, creatinine, leukocytes, ASAT, and ALAT), sociodemographic data (age, gender, income, education level, marital status, parenthood, and living area), and lifestyle factors. Multivariate linear regression models were applied to estimate the impact of each indicator on CRF. Results Overall, 90.6% of patients experienced some CRF, with 14.8% experiencing severe CRF. No gender difference was found in the prevalence of CRF. Patients with higher levels of pain, depressive symptoms, and lower Hb levels had significantly higher levels of CRF (ps <0.001). Lower levels of CRF were observed in patients who had children (p = 0.03), had less education (p
oncology